![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 33, 30253-30263, August 16, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Marlene and Stewart Greenebaum Cancer Center,
Department of Microbiology and Immunology, Molecular and Cellular
Biology Program, University of Maryland School of Medicine, Baltimore,
Maryland 21201 and the ¶ Division of Genetic Resources,
National Institute of Infectious Diseases, Tokyo 162-8640, Japan
We have previously identified a novel
interferon (IFN)-stimulated cis-acting enhancer element,
A Novel Transactivating Factor That Regulates
Interferon-
-dependent Gene Expression*
§,
,
,
-IFN-activated transcriptional element (GATE). GATE differs from the
known IFN-stimulated elements in its primary sequence. Preliminary
analysis has indicated that the GATE-dependent
transcriptional response requires the binding of novel transacting
factors. A cDNA expression library derived from an
IFN-
-stimulated murine macrophage cell line was screened with a
32P-labeled GATE probe to identify the potential
GATE-binding factors. A cDNA coding for a novel
transcription-activating factor was identified. Based on its discovery,
we named it as GATE-binding factor-1 (GBF-1). GBF-1 homologs are
present in mouse, human, monkey, and Drosophila. It
activates transcription from reporter genes carrying GATE. It possesses
a strong transactivating activity but has a weak DNA binding property.
GBF-1 is expressed in most tissues with relatively higher steady-state
levels in heart, liver, kidney, and brain. Its expression is induced by
IFN-
treatment. GBF-1 is present in both cytosolic and nuclear
compartments. These studies thus identify a novel transactivating
factor in IFN signaling pathways.
*
This work was supported by Grants CA71401 and CA78282 from
the NCI, National Institutes of Health (to D. V. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
These authors contributed equally to this work.
§
Present address: Tongji Hospital, Tongji Medical College,
Huazhong University of Science and Technology, Wuhan, Peoples
Republic of China.
To whom correspondence should be addressed: Greenebaum Cancer
Center, University of Maryland School of Medicine, 655 W. Baltimore St., BRB 9th Floor, Baltimore, MD 21201.
This article has been cited by other articles:
![]() |
M. E. Pennini, Y. Liu, J. Yang, C. M. Croniger, W. H. Boom, and C. V. Harding CCAAT/Enhancer-Binding Protein beta and {delta} Binding to CIITA Promoters Is Associated with the Inhibition of CIITA Expression in Response to Mycobacterium tuberculosis 19-kDa Lipoprotein J. Immunol., November 15, 2007; 179(10): 6910 - 6918. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Meng, A. Raha, S. Roy, J. Hu, and D. V. Kalvakolanu IFN-{gamma}-Stimulated Transcriptional Activation by IFN-{gamma}-Activated Transcriptional Element-Binding Factor 1 Occurs via an Inducible Interaction with CAAAT/Enhancer-Binding Protein-{beta} J. Immunol., May 15, 2005; 174(10): 6203 - 6211. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guay, K. Bateman, R. Gordon, J. Mancini, and D. Riendeau Carrageenan-induced Paw Edema in Rat Elicits a Predominant Prostaglandin E2 (PGE2) Response in the Central Nervous System Associated with the Induction of Microsomal PGE2 Synthase-1 J. Biol. Chem., June 4, 2004; 279(23): 24866 - 24872. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Murakami, K. Nakashima, D. Kamei, S. Masuda, Y. Ishikawa, T. Ishii, Y. Ohmiya, K. Watanabe, and I. Kudo Cellular Prostaglandin E2 Production by Membrane-bound Prostaglandin E Synthase-2 via Both Cyclooxygenases-1 and -2 J. Biol. Chem., September 26, 2003; 278(39): 37937 - 37947. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |